CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Phase 1 Completed
21 enrolled
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
Phase 1 Completed
20 enrolled
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Phase 1 Completed
160 enrolled
DUET-2
Phase 1 Completed
150 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 1 Completed
90 enrolled
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Phase 1 Completed
18 enrolled
VICORYX-2
Phase 1 Completed
11 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
Phase 1 Completed
158 enrolled 12 charts
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Phase 1 Completed
12 enrolled
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Phase 1 Completed
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Phase 1 Completed
26 enrolled
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Phase 1 Completed
15 enrolled
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
Phase 1 Completed
24 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase 1 Completed
20 enrolled